<DOC>
	<DOCNO>NCT02665845</DOCNO>
	<brief_summary>The role steroid treatment severe ulcerative colitis ( UC ) exacerbation well establish recommend professional society . Similarly , 5-aminosalycilates ( 5-ASA ) agent form mesalamine/mesalzine well establish proven therapy mild-moderate UC , combination oral 5-ASA topical ( per-rectal enema ) 5-ASA show superior oral 5ASA alone patient mild moderate UC . Thus , case , patient UC experience flare take 5-ASA therapy , treatment usually optimize maximize oral dose 4gr/day add topical therapy flare control . If unhelpful , flare severe begin , corticosteroid usually prescribe . However , scarce data compare steroid versus 5-ASA treatment severe UC exacerbation . The aim study compare efficacy steroid alone vs. combination steroid + 5-ASA treatment moderate-severe UC exacerbation .</brief_summary>
	<brief_title>Combination Corticosteroids+5-aminosalicylic Acids Compared Corticosteroids Alone ( Ulcerative Colitis ) .</brief_title>
	<detailed_description>The role steroid treatment severe ulcerative colitis ( UC ) exacerbation well establish recommend professional society . This recommendation base pivotal study carry 50-60 year ago , Truelove &amp; Witts . Similarly , 5-aminosalycilates ( 5-ASA ) agent form mesalamine/mesalzine well establish proven therapy mild-moderate UC , combination oral 5-ASA topical ( per-rectal enema ) 5-ASA show superior oral 5ASA alone patient mild moderate UC . Thus , case , patient UC experience flare take 5-ASA therapy , treatment usually optimize maximize oral dose 4gr/day add topical therapy flare control . If unhelpful , flare severe begin , corticosteroid usually prescribe . However , scarce data compare steroid versus 5-ASA treatment severe UC exacerbation . In 1962 truelove et al compare topical systemic corticosteroid therapy sulphasalazine , find steroid superior sulfasalazine . Importantly , data investigate whether addition and/or continuation 5-ASA agent combination therapy systemic corticosteroid superior corticosteroid alone patient moderate-severe active UC . This knowledge gap pronounce patient admitted hospital intravenous corticosteroid treatment moderate severe UC flare , currently unknown addition 5-ASA ( Oral and/or topical ) corticosteroid confer additional benefit improve patient outcomes . Thus , practical term , decision whether stop continue 5-ASA treatment whether add 5-ASA steroid treatment moderate-severe UC exacerbation take arbitrary basis . This important shortcoming knowledge gap current medicine , patient admit moderate-severe UC flare respond corticosteroid require salvage therapy infliximab , cyclosporine , even urgent colectomy . This make prudent explore avenue possible improvement response corticosteroid set , instance addition 5ASA . The aim study : To compare efficacy steroid alone vs. combination steroid + 5-ASA treatment moderate- severe UC exacerbation .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Aminosalicylic Acid</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>UC know diagnose establish clinicalendoscopic histological criterion newlydiagnosed UC , base clinical endoscopic finding , start treatment corticosteroid . Current hospitalization Severe UC exacerbation define Lichtiger score &gt; 10 Age &gt; 18 Has oral systemic corticosteroid 14 day prior hospitalization If take thiopurine , dose need stable last 2 month admission Pregnant woman Allergy / unable take prednisone / hydrocortisone/ 5ASA . Active infection either enteric elsewhere Severe renal , liver cardio respiratory comorbidity Toxic megacolon , clinical feature suggestive need imminent colectomy Treatment antiTNF within prior 3 month Prior treatment cyclosporine tacrolimus within prior 3 month Alcohol dependency Unable unwilling provide inform consent Participating clinical trial within 2 month prior admission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>